{
    "mainTopic": {
        "title": "Trophoblastic neoplasia",
        "content_info": "The uploaded materials in the PDF files are sometimes in outline form, not as continuous text, therefore it does not include every information but serves as a great foundation to form the questions and provide focus on core content, however additional background knowledge is needed to create quality revision quizzes. Some subtopics of certain topics do not follow each other in order.",
        "subTopics": [
            {
                "title": "Types of trophoblast neoplasia",
                "quizzes": [
                    {
                        "question": "Which of the following options accurately categorizes the spectrum of gestational trophoblastic diseases (GTD) into benign and malignant classifications, highlighting the clinically relevant distinction for management and prognosis?",
                        "goodAnswer": "Gestational trophoblastic diseases are classified into benign forms, including hydatidiform moles (complete and partial), and malignant forms encompassing invasive mole, gestational choriocarcinoma, placental site trophoblastic tumor (PSTT), and epithelioid trophoblastic tumor (ETT).",
                        "wrongAnswer_1": "Gestational trophoblastic diseases are classified into benign forms, including hydatidiform moles (complete and partial) and placental site trophoblastic tumor (PSTT), and malignant forms encompassing invasive mole and gestational choriocarcinoma.",
                        "wrongAnswer_2": "Gestational trophoblastic diseases are classified into benign forms, solely represented by partial hydatidiform moles, and malignant forms encompassing complete hydatidiform moles, invasive mole, gestational choriocarcinoma, PSTT, and ETT.",
                        "wrongAnswer_3": "Gestational trophoblastic diseases are classified into benign forms, exclusively including complete hydatidiform moles, and malignant forms encompassing partial hydatidiform moles, invasive mole, gestational choriocarcinoma, PSTT, and ETT.",
                        "wrongAnswer_4": "Gestational trophoblastic diseases are classified into benign forms, including invasive mole and hydatidiform moles (complete and partial), and malignant forms encompassing gestational choriocarcinoma, PSTT and ETT."
                    },
                    {
                        "question": "In the spectrum of gestational trophoblastic tumors, identify the variant characterized by its non-metastatic nature yet significant local invasiveness into the uterine myometrium, typically arising after evacuation of a hydatidiform mole.",
                        "goodAnswer": "Invasive mole, also known as chorioadenoma destruens, is a gestational trophoblastic neoplasm defined by its aggressive local invasion into the myometrium, frequently following a molar pregnancy, without evidence of distant metastatic spread.",
                        "wrongAnswer_1": "Placental site trophoblastic tumor (PSTT) is a gestational trophoblastic neoplasm characterized by aggressive local invasion into the myometrium, commonly presenting after a normal pregnancy, and defined by the absence of distant metastasis.",
                        "wrongAnswer_2": "Gestational choriocarcinoma is a gestational trophoblastic neoplasm known for its aggressive local invasion into the myometrium, typically occurring after an ectopic pregnancy, and characterized by its lack of distant metastatic potential.",
                        "wrongAnswer_3": "Epithelioid trophoblastic tumor (ETT) is a gestational trophoblastic neoplasm distinguished by its aggressive local invasion into the myometrium, predominantly following an abortion, and defined by its non-metastatic behavior.",
                        "wrongAnswer_4": "Complete hydatidiform mole, when persistent, can be referred to as a gestational trophoblastic neoplasm with aggressive local invasion into the myometrium, usually developing after a prior partial mole, but it remains non-metastatic."
                    },
                    {
                        "question": "Which specific type of gestational trophoblastic neoplasm originates from intermediate trophoblastic cells and is recognized for producing relatively lower levels of serum hCG in comparison to its tumor volume, alongside an increased risk for delayed metastatic dissemination?",
                        "goodAnswer": "Placental site trophoblastic tumor (PSTT) is derived from intermediate trophoblasts, typically exhibiting lower serum hCG levels relative to tumor mass, and is associated with a propensity for late metastasis, sometimes occurring several years post-pregnancy.",
                        "wrongAnswer_1": "Gestational choriocarcinoma is derived from cytotrophoblasts and syncytiotrophoblasts, characteristically presenting with lower serum hCG levels relative to tumor burden, and demonstrates a heightened risk for late metastases, even decades after gestation.",
                        "wrongAnswer_2": "Invasive mole, originating from villous trophoblasts, is distinguished by lower serum hCG levels compared to tumor size, and is known for its potential for late metastasis, typically manifesting many years following the preceding pregnancy.",
                        "wrongAnswer_3": "Epithelioid trophoblastic tumor (ETT), derived from chorionic-type intermediate trophoblasts, is identified by lower serum hCG levels relative to tumor volume, and carries a significant risk for late metastasis, often emerging years after the initial pregnancy.",
                        "wrongAnswer_4": "Complete hydatidiform mole, when invasive, is characterized by lower serum hCG levels in proportion to the extent of invasion, and is associated with a risk of late metastasis, although this is generally observed within the first year postpartum."
                    }
                ]
            },
            {
                "title": "Partial Hydatidiform Mole",
                "quizzes": [
                    {
                        "question": "Elaborate on the common genetic aberration underlying partial hydatidiform moles, specifying the typical karyotype and the parental origin of the additional chromosomal set that leads to this condition.",
                        "goodAnswer": "Partial hydatidiform moles are typically triploid, with the most frequent karyotype being 69,XXY, resulting from the fertilization of a single ovum by two spermatozoa or by a diploid sperm, thus introducing an extra paternal haploid set of chromosomes.",
                        "wrongAnswer_1": "Partial hydatidiform moles are typically diploid, with the most common karyotype being 46,XX, arising from the fertilization of an empty ovum by a single sperm which subsequently duplicates its chromosomes, leading to a purely paternal genome.",
                        "wrongAnswer_2": "Partial hydatidiform moles are typically tetraploid, with the most frequent karyotype being 92,XXXX, originating from the fertilization of a normal ovum by three spermatozoa or a triploid sperm, resulting in two additional paternal chromosome sets.",
                        "wrongAnswer_3": "Partial hydatidiform moles are typically aneuploid, characterized by variable karyotypes ranging from 45 to 70 chromosomes, arising from errors in maternal meiosis and subsequent fertilization by a single sperm with normal ploidy.",
                        "wrongAnswer_4": "Partial hydatidiform moles are typically haploid, with the most common karyotype being 23,X, resulting from the parthenogenic activation of an ovum without sperm fertilization, leading to a genome solely of maternal origin and reduced chromosomal content."
                    },
                    {
                        "question": "Describe the key microscopic features that pathologically define a partial hydatidiform mole, focusing on the distinctive characteristics of the chorionic villi, the nature of trophoblastic proliferation, and the potential presence of fetal components.",
                        "goodAnswer": "Partial hydatidiform moles histologically exhibit a mixture of normal-sized and hydropic villi, often with scalloped contours and stromal trophoblastic inclusions, displaying focal and mild trophoblastic hyperplasia, and may contain identifiable fetal erythrocytes or fetal tissue.",
                        "wrongAnswer_1": "Partial hydatidiform moles are characterized histologically by uniformly enlarged hydropic villi with smooth contours and absent stromal trophoblastic inclusions, showing circumferential and marked trophoblastic hyperplasia, and consistently lack fetal erythrocytes or fetal tissue.",
                        "wrongAnswer_2": "Partial hydatidiform moles are distinguished histologically by uniformly small and fibrotic villi with irregular contours and prominent stromal trophoblastic inclusions, displaying minimal and focal trophoblastic hyperplasia, and always contain fetal erythrocytes and fetal tissue.",
                        "wrongAnswer_3": "Partial hydatidiform moles are identified histologically by a homogenous population of normal-sized villi with smooth contours and absent stromal trophoblastic inclusions, exhibiting extensive and circumferential trophoblastic hyperplasia, and never contain fetal erythrocytes or fetal tissue.",
                        "wrongAnswer_4": "Partial hydatidiform moles are defined histologically by a combination of atrophic and hydropic villi with scalloped contours and variable stromal trophoblastic inclusions, displaying diffuse and moderate trophoblastic hyperplasia, and may contain fetal erythrocytes but not fetal tissue."
                    },
                    {
                        "question": "Outline the typical clinical presentation associated with partial hydatidiform moles, contrasting it with complete hydatidiform moles in terms of common symptoms, serum hCG levels, and usual diagnostic timing relative to gestational age.",
                        "goodAnswer": "Partial hydatidiform moles often manifest clinically as a missed or incomplete abortion in the first trimester, typically with lower than expected serum hCG levels for gestational age compared to complete moles, and frequently diagnosed following uterine evacuation for presumed spontaneous miscarriage.",
                        "wrongAnswer_1": "Partial hydatidiform moles typically present with hyperemesis gravidarum and early-onset preeclampsia in the second trimester, associated with markedly elevated serum hCG levels similar to complete moles, and usually diagnosed prenatally based on routine second-trimester ultrasound screening.",
                        "wrongAnswer_2": "Partial hydatidiform moles clinically resemble ectopic pregnancies with acute pelvic pain and adnexal masses in the first trimester, characterized by extremely low serum hCG levels compared to complete moles, and are diagnosed primarily through laparoscopic evaluation.",
                        "wrongAnswer_3": "Partial hydatidiform moles often present asymptomatically in the third trimester with normal fetal movement and growth, showing physiologic serum hCG levels comparable to normal pregnancies, and are typically diagnosed incidentally at the time of delivery or postpartum placental examination.",
                        "wrongAnswer_4": "Partial hydatidiform moles typically present with heavy vaginal bleeding and uterine enlargement in the first trimester, accompanied by significantly elevated serum hCG levels exceeding those seen in complete moles, and are usually diagnosed based on clinical symptoms and pelvic examination."
                    }
                ]
            },
            {
                "title": "Complete hydatidiform mole",
                "quizzes": [
                    {
                        "question": "Detail the genetic composition of a complete hydatidiform mole, particularly explaining the origin of its diploid chromosome set and the typical karyotype observed in these molar pregnancies.",
                        "goodAnswer": "Complete hydatidiform moles are genetically diploid, most commonly exhibiting a 46,XX karyotype, with chromosomes entirely of paternal origin, resulting from fertilization of an enucleated ovum by a single sperm that duplicates its chromosomes or by two sperm.",
                        "wrongAnswer_1": "Complete hydatidiform moles are genetically triploid, typically showing a 69,XXY karyotype, with chromosomes derived from both maternal and paternal sources, originating from fertilization of a normal ovum by two spermatozoa.",
                        "wrongAnswer_2": "Complete hydatidiform moles are genetically haploid, frequently displaying a 23,X karyotype, with chromosomes exclusively of maternal origin, arising from parthenogenic activation of an ovum without any sperm contribution.",
                        "wrongAnswer_3": "Complete hydatidiform moles are genetically tetraploid, usually presenting with a 92,XXXX karyotype, with chromosomes originating from both maternal and paternal lines, resulting from mitotic errors in the early zygote post-fertilization.",
                        "wrongAnswer_4": "Complete hydatidiform moles are genetically aneuploid, characterized by variable chromosome numbers and mosaicism, with chromosomes derived from a chaotic mixture of maternal and paternal sources due to abnormal meiotic events."
                    },
                    {
                        "question": "Identify the characteristic histopathological hallmarks that consistently define complete hydatidiform moles, distinguishing them from partial moles and normal placental tissues, with emphasis on villous morphology and trophoblastic proliferation patterns.",
                        "goodAnswer": "Complete hydatidiform moles are histologically defined by diffuse hydropic villi showing circumferential trophoblastic hyperplasia, involving both cytotrophoblast and syncytiotrophoblast layers, and a notable absence of fetal vessels and fetal red blood cells within the villous stroma.",
                        "wrongAnswer_1": "Complete hydatidiform moles are histologically characterized by focal hydropic villi with focal trophoblastic hyperplasia, predominantly affecting cytotrophoblasts only, and the presence of fetal vessels and fetal red blood cells within some villi.",
                        "wrongAnswer_2": "Complete hydatidiform moles are histologically identified by fibrotic and atrophic villi with minimal trophoblastic proliferation, primarily of the syncytiotrophoblast layer, and the absence of fetal vessels but presence of fetal red blood cells in the villous cores.",
                        "wrongAnswer_3": "Complete hydatidiform moles are histologically distinguished by normal-appearing chorionic villi with circumferential trophoblastic hyperplasia, predominantly of the syncytiotrophoblast layer, and the presence of both fetal vessels and fetal red blood cells in most villi.",
                        "wrongAnswer_4": "Complete hydatidiform moles are histologically marked by diffuse hydropic villi with focal trophoblastic hyperplasia, involving only the syncytiotrophoblast layer, and the presence of fetal vessels but absence of fetal red blood cells in the villous stroma."
                    },
                    {
                        "question": "Describe the typical clinical presentations and diagnostic modalities employed for complete hydatidiform moles, highlighting the role of serum hCG measurements and ultrasound findings in diagnosis and differentiation from other gestational conditions.",
                        "goodAnswer": "Complete hydatidiform moles typically present with first-trimester vaginal bleeding, markedly elevated serum hCG levels, and a 'snowstorm' appearance on ultrasound without a fetus; bilateral theca lutein cysts are frequently observed in the ovaries.",
                        "wrongAnswer_1": "Complete hydatidiform moles typically present with abdominal pain and amenorrhea, mildly elevated serum hCG levels similar to normal pregnancy, and ultrasound showing a viable fetus with normal amniotic fluid; theca lutein cysts are rarely present.",
                        "wrongAnswer_2": "Complete hydatidiform moles typically present with hyperemesis gravidarum and hypertension, normal or slightly elevated serum hCG levels, and ultrasound revealing a single gestational sac with a fetal pole and yolk sac; theca lutein cysts are commonly absent.",
                        "wrongAnswer_3": "Complete hydatidiform moles typically present with preterm labor symptoms and premature rupture of membranes, moderately elevated serum hCG levels, and ultrasound demonstrating multiple gestational sacs with fetal demise; theca lutein cysts are consistently large and bilateral.",
                        "wrongAnswer_4": "Complete hydatidiform moles typically present asymptomatically in early pregnancy, with very low serum hCG levels comparable to non-pregnant states, and ultrasound showing a normal intrauterine pregnancy with a single fetus; theca lutein cysts are frequently unilateral and small."
                    }
                ]
            },
            {
                "title": "Molar gestations",
                "quizzes": [
                    {
                        "question": "Differentiate between complete and partial hydatidiform moles based on their distinct genetic origins, specifically focusing on the parental contribution and ploidy status inherent to each type of molar pregnancy.",
                        "goodAnswer": "Complete hydatidiform moles are genetically diploid and androgenetic, derived solely from paternal chromosomes, typically 46,XX, while partial hydatidiform moles are typically triploid, resulting from polyspermic fertilization of a normal ovum, incorporating both maternal and paternal genetic contributions.",
                        "wrongAnswer_1": "Complete hydatidiform moles are genetically triploid and androgenetic, derived exclusively from paternal chromosomes, usually 69,XXY, whereas partial hydatidiform moles are typically diploid, resulting from fertilization of an empty ovum by a single sperm, leading to purely paternal genetic origin.",
                        "wrongAnswer_2": "Complete hydatidiform moles are genetically haploid and gynogenetic, derived entirely from maternal chromosomes, typically 23,X, whereas partial hydatidiform moles are typically tetraploid, resulting from fertilization of a normal ovum by three sperm, predominantly contributing maternal genetic material.",
                        "wrongAnswer_3": "Complete hydatidiform moles are genetically tetraploid and biparental, derived from both maternal and paternal chromosomes, usually 92,XXXX, whereas partial hydatidiform moles are typically haploid, resulting from parthenogenic activation of an ovum, leading to exclusively maternal genetic content.",
                        "wrongAnswer_4": "Complete hydatidiform moles are genetically diploid and biparental, derived from both maternal and paternal chromosomes, usually 46,XY, whereas partial hydatidiform moles are typically triploid, resulting from fertilization of an empty ovum by a single sperm, leading to purely paternal genetic material."
                    },
                    {
                        "question": "Compare and contrast the histopathological characteristics of complete and partial hydatidiform moles, specifically highlighting the differences in villous morphology, trophoblastic proliferation extent and pattern, and the presence or absence of fetal elements.",
                        "goodAnswer": "Complete hydatidiform moles exhibit diffuse hydropic swelling of villi, circumferential trophoblastic hyperplasia, and absence of fetal parts, whereas partial hydatidiform moles show a mixture of normal and hydropic villi, focal trophoblastic proliferation, and potential presence of fetal tissue or fetal erythrocytes.",
                        "wrongAnswer_1": "Complete hydatidiform moles exhibit focal hydropic swelling of villi, focal trophoblastic hyperplasia, and presence of fetal parts, whereas partial hydatidiform moles show exclusively hydropic villi, circumferential trophoblastic hyperplasia, and consistent absence of fetal tissue or fetal erythrocytes.",
                        "wrongAnswer_2": "Complete hydatidiform moles show fibrotic and atrophic villi, minimal trophoblastic proliferation, and absence of fetal parts, whereas partial hydatidiform moles exhibit normal villi with mild edema, extensive trophoblastic proliferation, and constant presence of fetal tissue and fetal erythrocytes.",
                        "wrongAnswer_3": "Complete hydatidiform moles show normal chorionic villi with mild edema, circumferential trophoblastic hyperplasia, and presence of fetal parts, whereas partial hydatidiform moles exhibit fibrotic and hydropic villi, minimal trophoblastic proliferation, and consistent absence of fetal tissue and fetal erythrocytes.",
                        "wrongAnswer_4": "Complete hydatidiform moles show diffuse hydropic swelling of villi, minimal trophoblastic proliferation, and presence of fetal parts, whereas partial hydatidiform moles exhibit a mixture of normal and hydropic villi, circumferential trophoblastic hyperplasia, and potential absence of fetal tissue or fetal erythrocytes."
                    },
                    {
                        "question": "Describe the typical clinical presentations and diagnostic approaches for both complete and partial hydatidiform moles, emphasizing the differences in serum hCG levels, sonographic appearances, and the subsequent risk of persistent gestational trophoblastic neoplasia (GTN).",
                        "goodAnswer": "Complete hydatidiform moles typically present with higher serum hCG levels, a 'snowstorm' ultrasound appearance, and a greater risk of GTN, while partial hydatidiform moles present with lower serum hCG levels, ultrasound features suggestive of missed abortion, and a lower GTN risk, often diagnosed post-dilation and curettage.",
                        "wrongAnswer_1": "Complete hydatidiform moles typically present with lower serum hCG levels, a normal pregnancy ultrasound appearance, and a reduced risk of GTN, while partial hydatidiform moles present with higher serum hCG levels, a 'snowstorm' ultrasound appearance, and an elevated GTN risk, usually diagnosed preoperatively.",
                        "wrongAnswer_2": "Complete hydatidiform moles typically present with normal serum hCG levels, an ultrasound appearance of fetal demise, and a moderate risk of GTN, while partial hydatidiform moles present with slightly elevated serum hCG levels, ultrasound features of molar tissue, and a moderate GTN risk, diagnosed antenatally.",
                        "wrongAnswer_3": "Complete hydatidiform moles typically present with extremely high serum hCG levels, a 'normal placenta' ultrasound appearance, and no risk of GTN, while partial hydatidiform moles present with very low serum hCG levels, an 'ectopic pregnancy' ultrasound appearance, and a significant GTN risk, diagnosed post-hysterectomy.",
                        "wrongAnswer_4": "Complete hydatidiform moles typically present with moderately elevated serum hCG levels, ultrasound showing 'theca lutein cysts only', and minimal GTN risk, while partial hydatidiform moles present with normal serum hCG levels, a 'normal pregnancy' ultrasound appearance, and minimal GTN risk, diagnosed incidentally at delivery."
                    }
                ]
            },
            {
                "title": "Choriocarcinoma",
                "quizzes": [
                    {
                        "question": "Define gestational choriocarcinoma and describe its typical cellular composition and differentiation patterns, contrasting it with other forms of gestational trophoblastic neoplasia.",
                        "goodAnswer": "Gestational choriocarcinoma is a malignant epithelial neoplasm of trophoblastic cells exhibiting biphasic pattern of syncytiotrophoblasts and cytotrophoblasts without identifiable villi, distinguished by its aggressive nature and potential for widespread metastasis.",
                        "wrongAnswer_1": "Gestational choriocarcinoma is a benign mesenchymal neoplasm of trophoblastic cells exhibiting a monophasic pattern of cytotrophoblasts only with identifiable villi, distinguished by its indolent nature and localized uterine growth.",
                        "wrongAnswer_2": "Gestational choriocarcinoma is a malignant mesenchymal neoplasm of trophoblastic cells exhibiting a triphasic pattern of syncytiotrophoblasts, cytotrophoblasts, and intermediate trophoblasts with identifiable villi, distinguished by its moderate aggressiveness and potential for regional metastasis.",
                        "wrongAnswer_3": "Gestational choriocarcinoma is a benign epithelial neoplasm of trophoblastic cells exhibiting a monophasic pattern of syncytiotrophoblasts only without identifiable villi, distinguished by its non-invasive nature and confinement to the endometrium.",
                        "wrongAnswer_4": "Gestational choriocarcinoma is a malignant epithelial neoplasm of decidual cells exhibiting a biphasic pattern of syncytiotrophoblasts and intermediate trophoblasts without identifiable villi, distinguished by its aggressive nature and propensity for lymphatic invasion."
                    },
                    {
                        "question": "What are the common clinical presentations of gestational choriocarcinoma, and how does its post-gestational occurrence influence its diagnosis and management, particularly in relation to antecedent pregnancies?",
                        "goodAnswer": "Gestational choriocarcinoma typically presents with irregular vaginal bleeding, elevated hCG levels following a molar pregnancy, normal pregnancy, abortion, or ectopic pregnancy; it can metastasize early and widely, affecting lungs, vagina, brain, and liver.",
                        "wrongAnswer_1": "Gestational choriocarcinoma typically presents with amenorrhea and abdominal pain, normal hCG levels following a normal pregnancy or delivery, it rarely metastasizes, and when it does, it primarily affects ovaries and fallopian tubes.",
                        "wrongAnswer_2": "Gestational choriocarcinoma typically presents with hyperemesis gravidarum and hypertension, mildly elevated hCG levels following a partial hydatidiform mole or invasive mole, it has a late metastatic potential, primarily spreading to bone and lymph nodes.",
                        "wrongAnswer_3": "Gestational choriocarcinoma typically presents with features of pre-eclampsia and proteinuria, undetectable hCG levels following a placental site trophoblastic tumor or epithelioid trophoblastic tumor, it is non-metastatic and always confined to the uterus.",
                        "wrongAnswer_4": "Gestational choriocarcinoma typically presents asymptomatically with normal vaginal bleeding and physiologic hCG levels following a complete hydatidiform mole or choriocarcinoma in situ; it metastasizes only locally and is readily treated with surgery alone."
                    },
                    {
                        "question": "Describe the prognostic factors and the widely used staging system for gestational choriocarcinoma, emphasizing the crucial role of risk stratification in guiding therapeutic decisions and predicting clinical outcomes for patients.",
                        "goodAnswer": "Prognosis in gestational choriocarcinoma is assessed using the FIGO staging system and WHO risk scoring, incorporating factors such as pre-treatment hCG levels, duration from antecedent pregnancy, presence of metastases, and prior chemotherapy history to stratify patients into low and high-risk groups for tailored treatment strategies.",
                        "wrongAnswer_1": "Prognosis in gestational choriocarcinoma is assessed using the TNM staging system and Gleason scoring, incorporating factors like primary tumor size, nodal involvement, distant metastases, and histologic tumor grade to categorize patients into early and advanced stages for uniform therapeutic protocols.",
                        "wrongAnswer_2": "Prognosis in gestational choriocarcinoma is assessed using the AJCC staging system and Nottingham Prognostic Index, incorporating factors such as patient age, parity, ethnicity, and socioeconomic status to categorize patients into favorable and unfavorable prognostic categories for palliative care approaches.",
                        "wrongAnswer_3": "Prognosis in gestational choriocarcinoma is assessed using the FIGO staging system and Dukes\u2019 staging, incorporating factors such as tumor location within the uterus, depth of myometrial invasion, lymphatic spread, and vascular invasion to categorize patients into localized and disseminated disease types for surgical resection planning.",
                        "wrongAnswer_4": "Prognosis in gestational choriocarcinoma is assessed using the TNM staging system and FIGO risk score, incorporating factors such as gestational age at diagnosis, fetal karyotype, placental weight, and number of prior pregnancies to categorize patients into low, intermediate, and high-risk groups for observational management only."
                    }
                ]
            },
            {
                "title": "Choriocarcinoma in situ",
                "quizzes": [
                    {
                        "question": "Define choriocarcinoma in situ and outline its diagnostic criteria, distinguishing it from invasive choriocarcinoma and other forms of gestational trophoblastic disease based on specific histological features and clinical behavior parameters.",
                        "goodAnswer": "Choriocarcinoma in situ is defined as trophoblastic neoplasia localized to the placental site within the endometrium, without myometrial invasion, diagnosed histologically by abnormal trophoblastic proliferation confined to the endometrial lining, representing a pre-invasive precursor to invasive choriocarcinoma.",
                        "wrongAnswer_1": "Choriocarcinoma in situ is defined as trophoblastic neoplasia characterized by extensive myometrial invasion and distant metastases, diagnosed clinically by markedly elevated hCG levels and radiographic evidence of widespread disease, representing an advanced metastatic stage of invasive choriocarcinoma.",
                        "wrongAnswer_2": "Choriocarcinoma in situ is defined as benign trophoblastic proliferation occurring within hydatidiform moles, diagnosed histologically by mild trophoblastic hyperplasia limited to hydropic villi, representing a non-neoplastic condition without potential for malignant transformation.",
                        "wrongAnswer_3": "Choriocarcinoma in situ is defined as placental site trophoblastic tumor confined to the placental bed, diagnosed immunohistochemically by specific markers of intermediate trophoblast dominance in the absence of syncytiotrophoblasts or cytotrophoblasts, representing a variant of PSTT.",
                        "wrongAnswer_4": "Choriocarcinoma in situ is defined as epithelioid trophoblastic tumor localized within endometrial polyps, diagnosed cytologically by atypical epithelioid cells exhibiting abundant cytoplasm and pleomorphic nuclei, representing a distinct subtype of ETT with benign behavior."
                    },
                    {
                        "question": "What is the clinical significance of choriocarcinoma in situ, and how is it typically managed in comparison to invasive choriocarcinoma, considering the inherent risk of progression to invasive disease and the spectrum of available treatment modalities?",
                        "goodAnswer": "Choriocarcinoma in situ is clinically significant as a pre-invasive lesion with a recognized potential to progress to invasive choriocarcinoma; typical management strategies involve local excision or uterine curettage, coupled with meticulous monitoring of serum hCG levels to promptly detect and treat any progression to invasive disease.",
                        "wrongAnswer_1": "Choriocarcinoma in situ is clinically considered a benign condition with no discernible risk of progression to invasive choriocarcinoma; typical management involves expectant observation with routine follow-up assessments but no active therapeutic intervention unless symptoms develop.",
                        "wrongAnswer_2": "Choriocarcinoma in situ is clinically considered an advanced metastatic disease requiring aggressive multi-agent chemotherapy and radical hysterectomy for definitive treatment and improved survival outcomes, similar to management of advanced invasive choriocarcinoma.",
                        "wrongAnswer_3": "Choriocarcinoma in situ is clinically considered a variant of placental site trophoblastic tumor requiring surgical resection followed by adjuvant radiation therapy for local disease control and prevention of late metastatic recurrence, aligning with PSTT management protocols.",
                        "wrongAnswer_4": "Choriocarcinoma in situ is clinically considered a form of epithelioid trophoblastic tumor requiring targeted therapy and immunotherapy for systemic treatment and achievement of long-term remission, distinct from management of invasive choriocarcinoma or PSTT."
                    },
                    {
                        "question": "Describe the key histopathological features that are characteristically observed in choriocarcinoma in situ, emphasizing the diagnostic criteria utilized for its identification and differentiation from normal placental tissue and invasive choriocarcinoma based on microscopic evaluation.",
                        "goodAnswer": "Histopathologically, choriocarcinoma in situ demonstrates abnormal proliferation of cytotrophoblasts and syncytiotrophoblasts confined to the endometrium, lacking formation of villous structures and myometrial invasion, while exhibiting nuclear atypia and increased mitotic activity compared to normal placental site.",
                        "wrongAnswer_1": "Histopathologically, choriocarcinoma in situ demonstrates normal proliferation of cytotrophoblasts and syncytiotrophoblasts with well-formed villous structures and extensive myometrial invasion, exhibiting minimal nuclear atypia and low mitotic activity, closely resembling normal placental tissue.",
                        "wrongAnswer_2": "Histopathologically, choriocarcinoma in situ demonstrates benign proliferation of intermediate trophoblasts with a prominent placental site reaction and decidualization, lacking syncytiotrophoblasts and cytotrophoblasts, while exhibiting no nuclear atypia and absent mitotic activity, typical of benign placental site changes.",
                        "wrongAnswer_3": "Histopathologically, choriocarcinoma in situ demonstrates malignant proliferation of epithelioid trophoblastic cells with abundant eosinophilic cytoplasm and pleomorphic nuclei, forming solid nests and cords without syncytiotrophoblasts or cytotrophoblasts, and invading deeply into the myometrium, characteristic of ETT.",
                        "wrongAnswer_4": "Histopathologically, choriocarcinoma in situ demonstrates focal proliferation of cytotrophoblasts exclusively within hydropic villi, confined to the villous stroma without syncytiotrophoblasts or myometrial invasion, exhibiting minimal nuclear atypia and occasional mitotic figures, suggestive of partial mole changes."
                    }
                ]
            },
            {
                "title": "Placental site trophoblastic tumor",
                "quizzes": [
                    {
                        "question": "Define placental site trophoblastic tumor (PSTT) and elaborate on its cellular origin and differentiation pathway, contrasting its characteristics with those of choriocarcinoma and other gestational trophoblastic neoplasms based on cellular lineage.",
                        "goodAnswer": "Placental site trophoblastic tumor (PSTT) is defined as a rare form of gestational trophoblastic neoplasia arising from intermediate trophoblasts of the placental bed, characterized by a monomorphic proliferation of intermediate trophoblasts with sparse syncytiotrophoblasts, distinguishing it from choriocarcinoma's biphasic composition.",
                        "wrongAnswer_1": "Placental site trophoblastic tumor (PSTT) is defined as a common form of gestational trophoblastic neoplasia originating from cytotrophoblasts of the chorionic villi, characterized by a polymorphic proliferation of cytotrophoblasts and syncytiotrophoblasts with identifiable villous structures, resembling hydatidiform mole morphologically.",
                        "wrongAnswer_2": "Placental site trophoblastic tumor (PSTT) is defined as a rare form of non-gestational trophoblastic neoplasia originating from germ cells within the ovary, characterized by a biphasic proliferation of syncytiotrophoblasts and cytotrophoblasts along with teratomatous elements, mimicking ovarian choriocarcinoma in presentation.",
                        "wrongAnswer_3": "Placental site trophoblastic tumor (PSTT) is defined as a common form of gestational trophoblastic neoplasia originating from syncytiotrophoblasts of the placental villi, characterized by a monomorphic proliferation of syncytiotrophoblasts only without cytotrophoblasts or intermediate trophoblasts, closely resembling gestational choriocarcinoma in cellular origin.",
                        "wrongAnswer_4": "Placental site trophoblastic tumor (PSTT) is defined as a rare form of metastatic trophoblastic neoplasia originating from distal implantation sites, characterized by a polymorphic proliferation of all three trophoblast types\u2014cytotrophoblasts, syncytiotrophoblasts, and intermediate trophoblasts\u2014resembling metastatic choriocarcinoma in its cellular diversity."
                    },
                    {
                        "question": "Describe the typical clinical features associated with placental site trophoblastic tumor (PSTT) and explain how serum hCG levels and patient obstetric history contribute to its diagnosis and differentiation from other causes of post-gestational uterine bleeding.",
                        "goodAnswer": "Placental site trophoblastic tumor (PSTT) typically presents with irregular vaginal bleeding or amenorrhea following a normal pregnancy, abortion, or molar gestation, characterized by disproportionately low serum hCG levels relative to tumor bulk, typically occurring months to years after the antecedent pregnancy.",
                        "wrongAnswer_1": "Placental site trophoblastic tumor (PSTT) typically presents with acute pelvic pain and fever following a recent delivery or cesarean section, characterized by markedly elevated serum hCG levels similar to choriocarcinoma, typically manifesting days to weeks within the immediate postpartum period.",
                        "wrongAnswer_2": "Placental site trophoblastic tumor (PSTT) typically presents with hyperemesis gravidarum and pre-eclampsia during the first trimester of a new pregnancy, characterized by moderately elevated serum hCG levels resembling hydatidiform mole, typically concurrent with a viable intrauterine pregnancy.",
                        "wrongAnswer_3": "Placental site trophoblastic tumor (PSTT) typically presents asymptomatically with normal menstrual cycles and baseline serum hCG levels, incidentally diagnosed during routine pelvic examinations, typically years prior to any documented antecedent pregnancy or gestational event.",
                        "wrongAnswer_4": "Placental site trophoblastic tumor (PSTT) typically presents with heavy vaginal bleeding and uterine enlargement during the second trimester of a new pregnancy, characterized by significantly suppressed serum hCG levels lower than normal pregnancy ranges, typically during an ongoing viable intrauterine gestation."
                    },
                    {
                        "question": "Elaborate on the distinctive histological characteristics of placental site trophoblastic tumor (PSTT), emphasizing the key microscopic features that differentiate it from other trophoblastic lesions and benign placental site tissue reactions based on cellular morphology and architectural patterns.",
                        "goodAnswer": "Placental site trophoblastic tumor (PSTT) is histologically characterized by a monomorphic proliferation of intermediate trophoblasts infiltrating the myometrium, exhibiting minimal cytologic atypia, low mitotic activity, and sparse syncytiotrophoblasts; fibrinoid deposition and extensive myometrial vessel infiltration are also typical.",
                        "wrongAnswer_1": "Placental site trophoblastic tumor (PSTT) is histologically characterized by a biphasic proliferation of cytotrophoblasts and syncytiotrophoblasts forming villous structures, exhibiting marked cytologic atypia, high mitotic activity, and abundant intermediate trophoblasts; extensive necrosis and hemorrhage are also prominent features.",
                        "wrongAnswer_2": "Placental site trophoblastic tumor (PSTT) is histologically characterized by a benign proliferation of decidual cells and extravillous trophoblasts confined to the endometrium, exhibiting no cytologic atypia, absent mitotic activity, and prominent stromal edema; glandular endometrial hyperplasia is frequently observed concurrently.",
                        "wrongAnswer_3": "Placental site trophoblastic tumor (PSTT) is histologically characterized by a polymorphic proliferation of all three trophoblast types\u2014cytotrophoblasts, syncytiotrophoblasts, and intermediate trophoblasts\u2014forming solid nests, exhibiting moderate cytologic atypia, intermediate mitotic activity, and scant fibrinoid material; lymphatic invasion is consistently present microscopically.",
                        "wrongAnswer_4": "Placental site trophoblastic tumor (PSTT) is histologically characterized by a monomorphic proliferation of epithelioid trophoblastic cells forming cords and nests within the endometrial stroma, exhibiting significant cytologic atypia, very high mitotic activity, and complete absence of syncytiotrophoblasts; extensive vascular invasion and distant metastases are invariably present at diagnosis."
                    },
                    {
                        "question": "What are the primary treatment modalities for placental site trophoblastic tumor (PSTT), and how does the management strategy contrast with that employed for choriocarcinoma, especially concerning chemotherapy sensitivity and the role of surgical intervention?",
                        "goodAnswer": "Hysterectomy is the primary treatment modality for PSTT due to its relative chemoresistance; chemotherapy is reserved for cases with metastatic disease or recurrent tumors, in contrast to choriocarcinoma, which is highly chemosensitive and often primarily treated with chemotherapy, with surgery playing a secondary role.",
                        "wrongAnswer_1": "Chemotherapy is the primary treatment modality for PSTT due to its high chemosensitivity; hysterectomy is reserved for cases refractory to chemotherapy or with localized disease, similar to choriocarcinoma, which is also primarily treated with chemotherapy and surgery as a salvage option for resistant cases.",
                        "wrongAnswer_2": "Radiation therapy is the primary treatment modality for PSTT due to its radiosensitivity; hysterectomy is reserved for cases with distant metastases or radiation therapy failure, unlike choriocarcinoma, which is radioresistant and treated primarily with surgery and chemotherapy combinations.",
                        "wrongAnswer_3": "Expectant management with close observation is the primary treatment modality for PSTT due to its benign clinical behavior and spontaneous regression tendencies; chemotherapy and hysterectomy are contraindicated because of potential treatment-related complications, similar to choriocarcinoma, managed conservatively without active intervention.",
                        "wrongAnswer_4": "Hysterectomy followed by adjuvant radiation therapy is the primary treatment for PSTT due to its local invasiveness and potential for regional recurrence; chemotherapy is reserved for cases with distant metastases, unlike choriocarcinoma, which is treated primarily with surgery and radiation therapy for localized disease management."
                    }
                ]
            }
        ],
        "team_name": "Bob\u00f3kocka"
    }
}
